Daniel Stauder
Stock Analyst at Citizens JMP
(4.24)
# 1,468
Out of 4,988 analysts
44
Total ratings
52.5%
Success rate
22.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Reiterated: Buy | $4 → $3 | $1.33 | +125.56% | 2 | Aug 27, 2026 | |
| AORT Artivion | Reiterated: Buy | $53 → $48 | $23.35 | +105.57% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Buy | $118 → $127 | $78.87 | +61.02% | 11 | May 6, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $60 → $52 | $58.10 | -10.50% | 15 | Feb 18, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $2.90 | n/a | 6 | Mar 5, 2025 |
Stereotaxis
Aug 27, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.33
Upside: +125.56%
Artivion
May 8, 2026
Reiterated: Buy
Price Target: $53 → $48
Current: $23.35
Upside: +105.57%
LeMaitre Vascular
May 6, 2026
Reiterated: Buy
Price Target: $118 → $127
Current: $78.87
Upside: +61.02%
AtriCure
Feb 18, 2026
Reiterated: Buy
Price Target: $60 → $52
Current: $58.10
Upside: -10.50%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $2.90
Upside: n/a